RLAY - Relay Therapeutics Inc
IEX Last Trade
6.8
0.040 0.588%
Share volume: 1,166,761
Last Updated: Fri 30 Aug 2024 09:59:58 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$6.76
0.04
0.59%
Summary score
18%
Profitability
25%
Dept financing
3%
Liquidity
75%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-10.86%
Return on assets
-8.54%
Return on sales
704812.72%
Return on invested capital
-642.52%
Total debt ratio
12.55%
Debt ratio change over timeo
-1.02%
Current Ratio
22.83%
Quick Ratio
22.83%
Cash Position Ratio
22.31%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-10.66%
Return on assets
-10.4%
Return on sales
2333538.98%
Return on invested capital
-578.99%
Total debt ratio
13.06%
Debt ratio change over timeo
-1.05%
Current Ratio
18.73%
Quick Ratio
18.73%
Cash Position Ratio
18.28%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-10.91%
Return on assets
-10.96%
Return on sales
-921.31%
Return on invested capital
-237.99%
Total debt ratio
11.37%
Debt ratio change over time
-1.06%
Current Ratio
20.73%
Quick Ratio
20.73%
Cash Position Ratio
20.18%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-98.21%
Return on assets
-98.39%
Return on sales
-301650.96%
Return on invested capital
6.11%
Total debt ratio
-102.13%
Debt ratio change over time
-1.02%
Current Ratio
-3.93%
Quick Ratio
-3.93%
Cash Position Ratio
-3.85%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | RLAY | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -10.86% | 13.79% | 34.47% | 7.43% |
| Return on assets | -8.54% | 2.76% | 3.15% | 5.62% |
| Return on sales | 704812.72% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | -642.52% | 2.36% | 5.39% | 19.77% |
| Profitability | 25% | 25% | 46% | 55% |
| Total debt ratio | 12.55% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -1.02% | 308.97% | -6.99% | 1.18% |
| Dept financing | 3% | 50% | 25% | 7% |
| Current Ratio | 18.73% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 18.73% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 18.28% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 2% | 5% | 11% |
| Short-term ratios | RLAY | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -10.66% | 13.77% | 13.25% | 3.8% |
| Return on assets | -10.4% | 2.43% | 1.89% | 3.09% |
| Return on sales | 2333538.98% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -578.99% | 2.14% | 3.39% | 9.18% |
| Profitability | 25% | 50% | 49% | 57% |
| Total debt ratio | 13.06% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -1.05% | 46.38% | -72.08% | 1.51% |
| Dept financing | 4% | 50% | 25% | 7% |
| Current Ratio | 18.73% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 18.73% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 18.28% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 3% | 7% | 17% |